What are the symptoms of Ehrlichiosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Symptoms of Ehrlichiosis

The primary symptoms of ehrlichiosis include fever (96%), headache (72%), malaise (77%), myalgia (68%), and gastrointestinal manifestations such as nausea (57%), vomiting (47%), and diarrhea (25%). 1

Common Symptoms

  • Fever: Nearly universal symptom (96% of cases)

  • Constitutional symptoms:

    • Headache (72%)
    • Malaise/fatigue (77%)
    • Muscle aches/myalgia (68%)
    • Shaking chills
  • Gastrointestinal manifestations:

    • Nausea (57%)
    • Vomiting (47%)
    • Diarrhea (25%)
    • Abdominal pain (more common in children)
  • Respiratory symptoms:

    • Cough (28% of patients)
    • More common in adults than children

Less Common but Important Symptoms

  • Rash: Present in approximately one-third of patients

    • More common in children than adults
    • Typically appears about 5 days after illness onset
    • Can be petechial, maculopapular, or diffuse erythema
    • Usually involves extremities and trunk, but can affect palms, soles, or face
  • Neurologic manifestations: Present in approximately 20% of patients

    • Can include meningitis or meningoencephalitis

Laboratory Findings

Characteristic laboratory abnormalities include:

  • Leukopenia (low white blood cell count)
  • Thrombocytopenia (low platelet count)
  • Elevated liver enzymes (hepatic transaminases)
  • Anemia (occurs later in the illness, seen in 50% of patients)
  • Mild to moderate hyponatremia

Variations by Ehrlichia Species

  1. Ehrlichia chaffeensis (Human Monocytic Ehrlichiosis)

    • All symptoms described above
    • Case-fatality rate approximately 3%
    • Morulae may be observed in monocytes
  2. Ehrlichia ewingii

    • Similar to E. chaffeensis but with fewer gastrointestinal symptoms
    • Rash is rare
    • No deaths reported
    • Morulae may be observed in granulocytes
  3. Ehrlichia muris-like agent (EML)

    • Fever (87%), malaise (76%), headache (67%), myalgia (60%)
    • Rash reported in only 12% of cases
    • No fatal cases reported

Severe Manifestations

In severe cases, ehrlichiosis can lead to:

  • Acute respiratory distress syndrome (ARDS)
  • Toxic shock-like or septic shock-like syndromes
  • Renal failure
  • Hepatic failure
  • Coagulopathies
  • Hemorrhagic complications

Risk Factors for Severe Disease

  • Age ≥60 years
  • Immunosuppression (HIV, organ transplantation, immunosuppressive therapy)
  • Young children (<10 years) have highest case-fatality rate
  • Receipt of sulfonamide antibiotics may predispose to severe illness

Important Clinical Considerations

  • Symptoms typically appear 5-14 days after tick bite (median 9 days for E. chaffeensis)
  • Early recognition is critical as delayed diagnosis and treatment can lead to increased mortality
  • The absence of rash does not rule out ehrlichiosis
  • Laboratory abnormalities are important diagnostic clues when clinical presentation is nonspecific

Remember that ehrlichiosis can be confused with other tick-borne diseases like Rocky Mountain spotted fever or anaplasmosis, but the specific pattern of symptoms and laboratory findings can help differentiate between these conditions 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ehrlichiosis and Anaplasmosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.